Abstract
Valsartan, a water-insoluble drug, is mainly used in the treatment of hypertension albeit with reduced oral bioavailability. The aim of work was to develop a valsartan:beta-cyclodextrin (VAL:beta-CD) pharmaceutical composition in order to improve its water solubility and bioavailability. The VAL:beta-CD complexes were prepared by the kneading, solid dispersion and freeze-drying methods, of which the freeze-drying method (FDY) was found to be the best to prepare an inclusion complex. A physical mixture PM was also prepared. Complexes were characterized by thermal analysis, Fourier transformed-infrared (FTIR) spectroscopy, Powder X-ray diffractometry, intrinsic dissolution and NMR (2D-ROESY). Phase-solubility analysis showed A(L)-type diagrams with beta-cyclodextrin (beta-CD). Microcalorimetric titrations suggested the formation of 1:1 inclusion complex between VAL and beta-CD. The apparent stability constants K(1:1) calculated from phase-solubility plots were 165.4 M(-1) (298 K), 145.0 M(-1) (303 K) and 111.3 M(-1) (310 K). In vivo experiments in rats showed that reduction in arterial pressure for the FDY complex is better than with valsartan used alone. The better activity of FDY can be attributed to the higher solubility of va...Continue Reading
References
Jan 23, 1998·American Journal of Hypertension·H R Brunner
Jan 5, 2000·American Journal of Hypertension·R M Zusman
Feb 19, 2002·Chemical Reviews·József Szejtli
Feb 19, 2002·Chemical Reviews·Hans-Jörg SchneiderHiroshi Ikeda
Feb 19, 2002·Chemical Reviews·Kaneto UekamaTetsumi Irie
Jul 12, 2002·Journal of Pharmaceutical and Biomedical Analysis·R FicarraP Ficarra
Dec 4, 2003·Journal of the American Chemical Society·W Bruce Turnbull, Antonio H Daranas
Jul 22, 2004·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Andrea BerniniNeri Niccolai
Dec 16, 2005·AAPS PharmSciTech·Rajeswari ChallaR K Khar
Jan 7, 2006·Journal of Human Hypertension·M Mohsen Ibrahim
Mar 11, 2006·Journal of Pharmaceutical and Biomedical Analysis·Mahmoud M Al OmariAdnan A Badwan
Mar 24, 2006·International Journal of Pharmaceutics·De-Zhi SunBao-Lin Yin
Dec 2, 2006·International Journal of Pharmaceutics·Thorsteinn Loftsson, Dominique Duchêne
Dec 21, 2006·Hypertension·Azra Mahmud, John Feely
Jan 2, 2007·International Journal of Pharmaceutics·Angelo M L DenadaiRubén D Sinisterra
Mar 3, 2007·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Hao LiJingkai Gu
Jun 29, 2007·Advanced Drug Delivery Reviews·N BlagdenP York
Jul 3, 2007·Advanced Drug Delivery Reviews·Marcus E Brewster, Thorsteinn Loftsson
Feb 12, 2008·Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy·Carolina JullianClaudio Olea-Azar
Citations
May 3, 2011·Chemical & Pharmaceutical Bulletin·Mitali KakranZaher Judeh
Dec 7, 2013·Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy·C ManivannanR Renganathan
May 13, 2014·Colloids and Surfaces. B, Biointerfaces·Diego F SuárezRubén D Sinisterra
Feb 28, 2015·Drug Development and Industrial Pharmacy·Sunny ShahJayant Chavda
Feb 10, 2016·Drug Development and Industrial Pharmacy·Kun ZhaoYue Li
Jan 4, 2012·Journal of Molecular Recognition : JMR·Rajesh GhaiBrett M Collins
May 2, 2013·Journal of Microencapsulation·Durga Maheswari ParvataneniLakshmi Narasu Mangamoori
Apr 24, 2018·Drug Development and Industrial Pharmacy·Washington X De PaulaRuben D Sinisterra
Jan 10, 2019·Hypertension·Ibra S FancherIrena Levitan
Jan 1, 2013·Journal of Pharmaceutics·Jyothi SanaboinaBuchi N Nalluri
Dec 31, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Eleni ChontzopoulouThomas Mavromoustakos
Apr 23, 2021·Journal of Pain Research·Anna StasiłowiczJudyta Cielecka-Piontek